CEF3, Influenza Virus M1 (13-21)

CEF3 is an M1-derived peptide supporting studies of matrix-protein folding and helix nucleation. Its sequence supports assessment of hydrophobic clustering. Researchers examine conformation to understand M1 assembly behavior. The molecule contributes to influenza structural biology.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: C14003

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide CDMOcGMP Peptide ServicePeptide Synthesis ServicesPeptide Analysis ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers